← back to search

Maya Dadiani

Sheba Medical Center · IL
Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Cells and Metastasis, Cancer, Stress, Anesthesia, and Immune Response, Cancer Genomics and Diagnostics, and Breast Cancer Treatment Studies.
h-index
16
citations
3,917
works
82
NIH funding
primary concept
Medicine
email

Recent publications

Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Cell 2022cited by 489position: middledoi
ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells
Frontiers in Immunology 2022cited by 21position: middledoi
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Science 2020cited by 2,341position: middledoi
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome
Nature Cancer 2020cited by 348position: middledoi
TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients
Cancer Immunology Immunotherapy 2020cited by 14position: firstdoi
Cancer-associated fibroblast compositions change with breast-cancer progression linking S100A4 and PDPN ratios with clinical outcome
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 11position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Einav Nili Gal‐Yam · Sheba Medical Center3 papers (2020–2020) · 2 papers (2020–2020)Carlos Caldas · Concern Foundation2 papers (2020–2020) · 2 papers (2020–2020) · 2 papers (2020–2020)Amir Giladi · Hubrecht Institute for Developmental Biology and Stem Cell Research2 papers (2020–2020)Ruth Scherz‐Shouval · Weizmann Institute of Science2 papers (2020–2020)Chamutal Bornstein · Weizmann Institute of Science2 papers (2020–2020)Gil Friedman · Hebrew University of Jerusalem2 papers (2020–2020) · 2 papers (2020–2020) · 2 papers (2020–2020)Eyal David · Weizmann Institute of Science2 papers (2020–2020)H. Raza Ali · University of Cambridge2 papers (2020–2020)Nora Balint‐Lahat · Tel Aviv University2 papers (2020–2020)Ido Amit · Weizmann Institute of Science2 papers (2020–2020) · 2 papers (2020–2020) · 2 papers (2020–2020)Iris Barshack · Tel Aviv University2 papers (2020–2020) · 2 papers (2020–2020)Massimo Saini · ETH Zurich1 papers (2022–2022)